3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
22
Prostatic Neoplasms
11
Osteoporosis
8
Vitamin D Deficiency
7
Polycystic Ovary Syndrome
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Colonic Neoplasms
5
Obesity
3
Neoplasms
3
Neoplasm Metastasis
3
Lung Neoplasms
3
Inflammation
3
Colorectal Neoplasms
3
Carcinoma, Hepatocellular
3
Bone Diseases, Metabolic
3
Multiple Endocrine Neoplasia Type 1
2
Motor Activity
2
Lymphoma
2
Leukemia
2
Leiomyoma
2
Giant Cell Tumor of Bone
2
Gastrointestinal Neoplasms
2
Cardiovascular Diseases
2
Carcinoma, Transitional Cell
2
Brain Neoplasms
2
Bone Diseases
2
Warts
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Interventions
Paclitaxel
95
Carboplatin
77
pembrolizumab
74
Cisplatin
29
Bevacizumab
27
Letrozole
22
Radiotherapy
21
Doxorubicin
21
Megestrol Acetate
20
lenvatinib
19
olaparib
18
Taxes
17
Docetaxel
17
Nivolumab
16
Specimen Handling
15
Metformin
15
dostarlimab
14
Magnetic Resonance Spectroscopy
14
Gemcitabine
13
durvalumab
12
Medroxyprogesterone Acetate
12
Trastuzumab
11
Indocyanine Green
11
Fulvestrant
11
Biopsy
11
temsirolimus
10
abemaciclib
10
atezolizumab
9
Radiation
9
Early Intervention, Educational
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Endometrial Neoplasms
×
Vitamin D
×
Clear all
NCT03192059
2021-09-08
PRIMMO
University Hospital, Ghent
Phase 2
Completed
43 enrolled